DocMorris AG
ZRSEF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.02 | 0.17 | -0.38 |
| FCF Yield | -23.22% | -16.81% | -1.29% | -9.33% |
| EV / EBITDA | -13.19 | -29.54 | -57.80 | -27.65 |
| Quality | ||||
| ROIC | 9.02% | -22.41% | 7.21% | 6.32% |
| Gross Margin | 22.34% | 20.99% | 21.61% | 6.09% |
| Cash Conversion Ratio | 0.90 | 0.25 | 0.31 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | -11.74% | -11.15% | -5.39% | 0.20% |
| Free Cash Flow Growth | -32.24% | -249.61% | 82.45% | -55.40% |
| Safety | ||||
| Net Debt / EBITDA | -5.22 | -13.56 | -13.74 | -7.46 |
| Interest Coverage | 6.83 | -166.90 | 3.21 | 16.33 |
| Efficiency | ||||
| Inventory Turnover | 9.70 | 11.10 | 8.79 | 9.19 |
| Cash Conversion Cycle | 7.92 | 7.19 | 8.45 | 12.36 |